Driehaus Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-68,294
| Closed | -$42.2M | – | 451 |
|
|
2024
Q3 | $42.2M | Buy |
68,294
+66,770
| +4,381% | +$41.3M | 0.36% | 92 |
|
|
2024
Q2 | $843K | Buy |
1,524
+653
| +75% | +$361K | 0.01% | 315 |
|
|
2024
Q1 | $506K | Buy |
871
+443
| +104% | +$257K | 0.01% | 348 |
|
|
2023
Q4 | $227K | Buy |
428
+13
| +3% | +$6.9K | ﹤0.01% | 364 |
|
|
2023
Q3 | $210K | Buy |
415
+23
| +6% | +$11.6K | ﹤0.01% | 384 |
|
|
2023
Q2 | $205K | Sell |
392
-15
| -4% | -$7.83K | ﹤0.01% | 375 |
|
|
2023
Q1 | $235K | Sell |
407
-37
| -8% | -$21.3K | ﹤0.01% | 364 |
|
|
2022
Q4 | $245K | Sell |
444
-22
| -5% | -$12.1K | ﹤0.01% | 332 |
|
|
2022
Q3 | $236K | Sell |
466
-38
| -8% | -$19.2K | ﹤0.01% | 335 |
|
|
2022
Q2 | $274K | Buy |
504
+20
| +4% | +$10.9K | ﹤0.01% | 330 |
|
|
2022
Q1 | $286K | Buy |
+484
| New | +$286K | ﹤0.01% | 360 |
|
|
2021
Q2 | – | Sell |
-851
| Closed | -$388K | – | 516 |
|
|
2021
Q1 | $388K | Buy |
851
+2
| +0.2% | +$912 | 0.01% | 395 |
|
|
2020
Q4 | $395K | Sell |
849
-37
| -4% | -$17.2K | 0.01% | 379 |
|
|
2020
Q3 | $391K | Buy |
+886
| New | +$391K | 0.01% | 350 |
|
|
2019
Q4 | – | Sell |
-693
| Closed | -$202K | – | 573 |
|
|
2019
Q3 | $202K | Sell |
693
-109
| -14% | -$31.8K | 0.01% | 473 |
|
|
2019
Q2 | $236K | Sell |
802
-203
| -20% | -$59.7K | 0.01% | 436 |
|
|
2019
Q1 | $275K | Buy |
+1,005
| New | +$275K | 0.01% | 364 |
|
|
2017
Q3 | – | Sell |
-1,313
| Closed | -$229K | – | 597 |
|
|
2017
Q2 | $229K | Sell |
1,313
-261
| -17% | -$45.5K | 0.01% | 498 |
|
|
2017
Q1 | $242K | Sell |
1,574
-155
| -9% | -$23.8K | 0.01% | 498 |
|
|
2016
Q4 | $244K | Buy |
+1,729
| New | +$244K | 0.01% | 487 |
|